Diagnos Laboratorium Utama PT Tbk Market Cap ($21.97 Million)
Market Cap & Net Worth: Diagnos Laboratorium Utama PT Tbk (DGNS)
Diagnos Laboratorium Utama PT Tbk market cap. Diagnos Laboratorium Utama PT Tbk (JK:DGNS) has a market capitalization of $21.97 Million (Rp375.00 Billion) as of November 3, 2026. Listed on the JK stock exchange, this Indonesia-based company holds position #24663 globally and #511 in its home market, demonstrating a 0.67% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Diagnos Laboratorium Utama PT Tbk's stock price Rp300.00 by its total outstanding shares 1250000000 (1.25 Billion). Also see Diagnos Laboratorium Utama PT Tbk cash conversion from operations for how efficiently the company converts equity into cash flow.
Diagnos Laboratorium Utama PT Tbk Market Cap History (2021–2026)
Diagnos Laboratorium Utama PT Tbk market cap history from 2021 to 2026. Data shows growth from $54.57 Million to $21.97 Million (1.91% CAGR). Check DGNS share price today for real-time trading data and today's change.
Index Memberships
Diagnos Laboratorium Utama PT Tbk is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Jakarta Stock Exchange Composite Index
JKSE
|
$413.93 Billion | 0.01% | #500 of 864 |
Weight: Diagnos Laboratorium Utama PT Tbk's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Diagnos Laboratorium Utama PT Tbk Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Diagnos Laboratorium Utama PT Tbk's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore DGNS shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
Diagnos Laboratorium Utama PT Tbk's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.02x
Diagnos Laboratorium Utama PT Tbk's market cap is 0.02 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $54.57 Million | $302.18 Billion | $64.30 Billion | 0.00x | 0.00x |
| 2022 | $17.87 Million | $192.89 Billion | $12.66 Billion | 0.00x | 0.00x |
| 2023 | $18.02 Million | $145.70 Billion | -$13.66 Billion | 0.00x | N/A |
| 2024 | $14.28 Million | $163.07 Billion | $747.44 Million | 0.00x | 0.02x |
Competitor Companies of DGNS by Market Capitalization
Companies near Diagnos Laboratorium Utama PT Tbk in the global market cap rankings as of November 3, 2026. Also see Diagnos Laboratorium Utama PT Tbk total assets for a full breakdown of the balance sheet.
Key companies related to Diagnos Laboratorium Utama PT Tbk by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #143 globally with a market cap of $161.03 Billion USD.
- Natera Inc (NASDAQ:NTRA): Ranked #493 globally with a market cap of $54.62 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #539 globally with a market cap of $50.18 Billion USD ( CN¥342.92 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $682.65 |
| #143 | Danaher Corporation | NYSE:DHR | $161.03 Billion | $227.97 |
| #493 | Natera Inc | NASDAQ:NTRA | $54.62 Billion | $378.92 |
| #539 | WuXi AppTec Co Ltd | SHG:603259 | $50.18 Billion | CN¥138.65 |
Market Capitalization of Diagnos Laboratorium Utama PT Tbk (2021–2026)
Market capitalization of Diagnos Laboratorium Utama PT Tbk from 2021 to today. Between 2021 and today, Diagnos Laboratorium Utama PT Tbk's market cap moved from $54.57 Million to $ 21.97 Million, with a yearly change of 1.91%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rp21.97 Million | +63.04% |
| 2025 | Rp13.48 Million | -5.64% |
| 2024 | Rp14.28 Million | -20.73% |
| 2023 | Rp18.02 Million | +0.82% |
| 2022 | Rp17.87 Million | -67.25% |
| 2021 | Rp54.57 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Diagnos Laboratorium Utama PT Tbk was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $21.97 Million USD |
| MoneyControl | $21.97 Million USD |
| MarketWatch | $21.97 Million USD |
| marketcap.company | $21.97 Million USD |
| Reuters | $21.97 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Diagnos Laboratorium Utama PT Tbk
PT Diagnos Laboratorium Utama Tbk provides health services using laboratories in Indonesia. The company offers clinical pathology laboratory tests comprising hematology, hemostasis, clinical chemistry, urinalysis, biomolecular, immunology, microbiology, and anatomical pathology; and genomics laboratory tests that provides genetic testing for reproductive health, pregnant women, couples who want t… Read more